Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- SENECAIndependent statistical analysis of Stem Cell Injection in Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02509156).
- SENIORIndependent statistical analysis of Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications: primary endpoint results, effect estimate…
- Senolytic Drugs Attenuate Osteoarthritis-Related Articular Cartilage Degeneration: A Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Senolytic Drugs Attenuate Osteoarthritis-Related Articular Cartilage Degeneration: A Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04210986).
- SENSE-HFIndependent statistical analysis of Sensitivity of the InSync Sentry OptiVol Feature for the Prediction of Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sensoril(Ashwaganhda)for Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Sensoril(Ashwaganhda)for Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00761761).
- Sensory Effects of Rapidly-Changing Magnetic Fields: Complete Statistical AnalysisIndependent statistical analysis of Sensory Effects of Rapidly-Changing Magnetic Fields: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01632800).
- Sensory Stimulation During CIMT: Complete Statistical AnalysisIndependent statistical analysis of Sensory Stimulation During CIMT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03558230).
- SensoryFLOIndependent statistical analysis of Effects of Acute Intermittent Hypoxia on Sensory Function in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SentimarkIndependent statistical analysis of Magnetic Seed Localisation of Breast Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02635737).
- Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.: Complete Statistical AnalysisIndependent statistical analysis of Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.: primary endpoint results, effect…
- SENTIOIndependent statistical analysis of Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SEPCELLIndependent statistical analysis of Cx611-0204 SEPCELL Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03158727).
- Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sequential and Hybrid Therapies for H Pylori Infection: Complete Statistical AnalysisIndependent statistical analysis of Sequential and Hybrid Therapies for H Pylori Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01085786).
- Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00856180).
- Sequential Vaccinations in Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Sequential Vaccinations in Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00060528).
- SequoiaIndependent statistical analysis of Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SEQUOIA-HCMIndependent statistical analysis of Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM: primary endpoint results, effect estimate with confidence interval, sample-size…
- SERAPHINIndependent statistical analysis of SERAPHIN, the randomized phase 3 trial of macitentan in symptomatic pulmonary arterial hypertension, including time-to-event endpoints, hazard ratios, confidence intervals, log-rank testing, and interpretation.
- SERAPHIN OLIndependent statistical analysis of Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size…
- SERCA-LVADIndependent statistical analysis of Investigation of the Safety and Feasibility of AAV1/SERCA2a Gene Transfer in Patients With Chronic Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SERENA-2Independent statistical analysis of A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative…
- SERENEIndependent statistical analysis of Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy: primary endpoint results, effect…
- SERENEIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis: primary endpoint results, effect…
- SERENITY IIIndependent statistical analysis of Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04276883).
- SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII): Complete Statistical AnalysisIndependent statistical analysis of SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00455923).
- SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery: Complete Statistical AnalysisIndependent statistical analysis of SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Serial [18F]Thymidine (FLT)PET/CT as a Biomarker of Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Serial [18F]Thymidine (FLT)PET/CT as a Biomarker of Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Serial Movement Assessment in Collegiate Athletes Who Perform Injury Prevention Training: Complete Statistical AnalysisIndependent statistical analysis of Serial Movement Assessment in Collegiate Athletes Who Perform Injury Prevention Training: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC): Complete Statistical AnalysisIndependent statistical analysis of Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04508725).
- Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic: Complete Statistical AnalysisIndependent statistical analysis of Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults: Complete Statistical AnalysisIndependent statistical analysis of Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05972733).
- Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors: Complete Statistical AnalysisIndependent statistical analysis of Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Seroprevalence of SARS-Cov-2 Antibodies in Children: Complete Statistical AnalysisIndependent statistical analysis of Seroprevalence of SARS-Cov-2 Antibodies in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04347408).
- Seroquel XR in Adults With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Seroquel XR in Adults With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00852631).
- Serratus Plane Block for Postoperative Pain Control: Complete Statistical AnalysisIndependent statistical analysis of Serratus Plane Block for Postoperative Pain Control: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02865928).
- Sert2Independent statistical analysis of A Trial of Sertraline in Young Children With Autism Spectrum Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Serum Levels of Bupivacaine in Autotransfusion Drains Following Total Joint Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Serum Levels of Bupivacaine in Autotransfusion Drains Following Total Joint Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Serum Markers in Gluten Challenge: Complete Statistical AnalysisIndependent statistical analysis of Serum Markers in Gluten Challenge: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00931892).
- Service Dog Training Program for Military Veterans With PTSD: Complete Statistical AnalysisIndependent statistical analysis of Service Dog Training Program for Military Veterans With PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03777020).
- Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity: Complete Statistical AnalysisIndependent statistical analysis of Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04966741).
- SETSIndependent statistical analysis of Statins for the Early Treatment of Sepsis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00528580).
- Severe Renal Disease Study in Fabry Patients Treated With Fabrazyme: Complete Statistical AnalysisIndependent statistical analysis of Severe Renal Disease Study in Fabry Patients Treated With Fabrazyme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00837824).
- Severing Nuchal Cord at the Time of Delivery.: Complete Statistical AnalysisIndependent statistical analysis of Severing Nuchal Cord at the Time of Delivery.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00345254).
- Sevoflurane Concentrations in Children: Complete Statistical AnalysisIndependent statistical analysis of Sevoflurane Concentrations in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06510803).
- SEVOPROTECTIONIndependent statistical analysis of Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevorane in Adult Patients Required General Anesthesia for Surgery in Terms of Quality of Anesthesia and Its Influence on…
- SEVOPROTECTIONIndependent statistical analysis of Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevorane in Adult Patients Requiring General Anesthesia for Surgery in Terms of Quality of Anesthesia and Its Influence on…
- Sex Differences in the Dilatory Response of Compound 21: Complete Statistical AnalysisIndependent statistical analysis of Sex Differences in the Dilatory Response of Compound 21: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05576155).